REKVINA LABS SHARE PRICE

Rekvina Labs Limited was incorporated on 1st November 1988. From a small domestic company at inception in middle of 80`s, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore. It is registered in England and Wales as a Public Limited Company. The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements. It provide contract research and manufacturing services to customers. The Company is mainly engaged in manufacturing and marketing of pharmaceutical products. It presently operates into one business segment i.e. Copper Extrusion. The Company had launched a new product `REKSEAL`, a tissue adhesive for wound closure from the market in 1999-2000. Though there was persistent recessionary trend in the pharmaceutical industry there is a decrease in the turnover of the Company which affected the. net worth of the Company adversely. In 2019-20, there was an overall slowdown in the economy. The Company incurred losses over a couple of years. The Company is focusing on strengthening its core business of manufacturing and marketing formulations. Research and Development (R&D) initiatives have been accelerated to improve cost competitiveness and ensure compliance with global regulatory requirements. Cost optimization, efficient resource utilization, and strong management control are being emphasized across all operations.

Rekvina Labs share price as on 10 Feb 2026 is Rs. 19.47. Over the past 6 months, the Rekvina Labs share price has increased by 0% and in the last one year, it has increased by 175%. The 52-week low for Rekvina Labs share price was Rs. 6.75 and 52-week high was Rs. 19.47.

Rekvina Labs Limited was incorporated on 1st November 1988. From a small domestic company at inception in middle of 80`s, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore. It is registered in England and Wales as a Public Limited Company. The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements. It provide contract research and manufacturing services to customers. The Company is mainly engaged in manufacturing and marketing of pharmaceutical products. It presently operates into one business segment i.e. Copper Extrusion. The Company had launched a new product `REKSEAL`, a tissue adhesive for wound closure from the market in 1999-2000. Though there was persistent recessionary trend in the pharmaceutical industry there is a decrease in the turnover of the Company which affected the. net worth of the Company adversely. In 2019-20, there was an overall slowdown in the economy. The Company incurred losses over a couple of years. The Company is focusing on strengthening its core business of manufacturing and marketing formulations. Research and Development (R&D) initiatives have been accelerated to improve cost competitiveness and ensure compliance with global regulatory requirements. Cost optimization, efficient resource utilization, and strong management control are being emphasized across all operations.

Rekvina Labs share price as on 10 Feb 2026 is Rs. 19.47. Over the past 6 months, the Rekvina Labs share price has increased by 0% and in the last one year, it has increased by 175%. The 52-week low for Rekvina Labs share price was Rs. 6.75 and 52-week high was Rs. 19.47.